Here's what it's going to take to turn the charts positive.
I see a rare attractive technical setup in this pharma name.
Maybe third time's the charm.
Collegium Pharmaceutical should benefit greatly from its pending purchase of my stock pick for this year, BioDelivery Sciences International.
I like the setup here with potential catalysts on the horizon and lucrative as well as liquid options available against the equity.
Even today's earnings beat is not 'moving the needle' enough.
Prices look like they can bounce further to the upside in the short-run but the longer-term picture is problematic.
Following earnings Wednesday morning, there's going to be some profit taking.
Here's what traders should do now.
Let's take a look at the charts and indicators.